John Patience

John Patience (board member) discloses dealings in 2 companies, chiefly Biodesix Inc and Accelerate Diagnostics, Inc. Over a trading history stretching from 9 February 2016 to 30 September 2026, the count stands at 21 filings.

Purchases make up the whole of the open-market record (11 purchases, €3.5M). The totals exclude 2 filings filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 2 share grants and 8 option exercises.

In size, the median ticket on the buying side is €95k. 8 out of 11 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. For 6 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 17% of cases, with a median move of -45.1%. This is a record of the past, not a forecast.

The newest entry dates from 2 October 2026: an option exercise, in Biodesix Inc. The latest purchase dates back some time: it was published 684 days ago, on 3 December 2024. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.